Gujarat Themis Biosyn Ltd. (GUJTHEM): Gujarat Themis Biosyn Share Price rises 5.33% to Rs 432.65
- August 31, 2026
- Posted by: Harsh Piplani
- Category: News
Gujarat Themis Biosyn Share Price moved higher today, with the stock closing at Rs 432.65 against the previous close of Rs 410.75. The share price rise of 5.33% added Rs 21.90 in a session that opened at Rs 409.80, touched a high of Rs 434.30 and held a low of Rs 409.80. The company’s market capitalisation now stands at Rs 5,345.98 crore, keeping Gujarat Themis Biosyn Share Price in focus in today’s market news.
The supplied data confirms the price event but does not establish a company-specific catalyst. What is clear is that Gujarat Themis Biosyn Share Price today is being assessed alongside its healthcare sector valuation, profitability metrics and peer benchmarks. For readers scanning Gujarat Themis Biosyn Stock News or Gujarat Themis Biosyn Share Price Today, the key point is the move itself, the day range and the current valuation backdrop. Univest tracks such stock updates with a focus on factual, event-led analysis rather than unsupported explanations.
Gujarat Themis Biosyn Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 432.65 |
| Previous Close | Rs 410.75 |
| Today's Move | Rs 21.9 (+5.33%) |
| Open | Rs 409.8 |
| High | Rs 434.3 |
| Low | Rs 409.8 |
| Turnover | Rs 1.17 crore |
| Market Capitalisation | Rs 5,345.98 crore |
| Market Cap Category | Mid Cap |
Gujarat Themis Biosyn Ltd. (GUJTHEM) rose to Rs 432.65 from the previous close of Rs 410.75, a move of Rs 21.9 or 5.33%. The stock opened at Rs 409.8, reached a high of Rs 434.3, recorded a low of Rs 409.8.
Gujarat Themis Biosyn Share Price rose Rs 21.90 from the previous close of Rs 410.75 to Rs 432.65, a gain of 5.33%. The day’s opening level was Rs 409.80, which was also the session low, while the high was Rs 434.30. That places the close near the upper end of the day’s range. Turnover for the session was Rs 1.17 crore. These figures describe the price action in Gujarat Themis Biosyn Share Price Today without adding any unverified reason for the move.
For readers following Gujarat Themis Biosyn Share News and Gujarat Themis Biosyn Share Price Live, the verified data shows a positive session, but it does not by itself explain why the stock was rising today. As always in Univest coverage, the event is treated as a price rise first, then examined through company numbers, sector comparison and peer context.
Gujarat Themis Biosyn Ltd. (GUJTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 5,345.98 crore |
| P/E Ratio | 109.8x |
| P/B Ratio | 5.1x |
| ROE | 21.69% |
| ROCE | 27.48% |
| EPS | Rs 3.74 |
| Book Value Per Share | Rs 80.59 |
| Dividend Yield | 0.16% |
Gujarat Themis Biosyn Ltd. (GUJTHEM) fundamental metrics show P/E 109.8x, P/B 5.1x, ROE 21.69%, ROCE 27.48%. These figures provide context only and are not a buy or sell signal.
Gujarat Themis Biosyn Ltd. has a market capitalisation of Rs 5345.98 crore and falls in the Mid Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 109.8x, P/B at 5.1x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.69% and ROCE of 27.48%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 3.74, book value per share of Rs 80.59, dividend yield of 0.16%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.21x, median ROE of 11.78%, median ROCE of 13.6%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 109.8x |
| Benchmark Median P/E | 31.21x |
| Benchmark Average P/E | 48.1x |
| Benchmark P/E Range | 3.7x to 672.45x |
| Company P/B Ratio | 5.1x |
| Benchmark Median P/B | 2.88x |
| Company ROE | 21.69% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 27.48% |
| Benchmark Median ROCE | 13.6% |
| Company Market Capitalisation | Rs 5,345.98 crore |
| Benchmark Median Market Cap | Rs 670.73 crore |
Gujarat Themis Biosyn Ltd. (GUJTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Gujarat Themis Biosyn Ltd. (GUJTHEM) has a P/E ratio of 109.8x, which is above the benchmark median of 31.21x, a difference of +251.81%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Gujarat Themis Biosyn Ltd. (GUJTHEM) has a ROE of 21.69%, which is above the benchmark median of 11.78%, a difference of +84.13%. Gujarat Themis Biosyn Ltd. (GUJTHEM) has a ROCE of 27.48%, which is above the benchmark median of 13.6%, a difference of +102.06%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,60,696.31 | 38.09 | 5.33 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,46,062.83 | 84.12 | 13.93 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,91,515.22 | 87.81 | 21.34 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,18,403.7 | 26.24 | 4.39 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.99 | 3.26 | 11.83 | 16 |
Gujarat Themis Biosyn Ltd. (GUJTHEM) has a P/E ratio of 109.8x compared with the displayed peer median of 38.09x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.69% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 27.48% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Gujarat Themis Biosyn Ltd. (GUJTHEM) has a market capitalisation of Rs 5,345.98 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Gujarat Themis Biosyn
- Gujarat Themis Biosyn Share Price rose 5.33% today to Rs 432.65 after closing above the previous close of Rs 410.75.
- The day’s range moved between Rs 409.80 and Rs 434.30, with turnover of Rs 1.17 crore.
- Market capitalisation stands at Rs 5,345.98 crore, which places the company above the same-industry median market cap.
- P/E of 109.8 and P/B of 5.1 are above the same-industry benchmark median and average.
- ROE of 21.69% and ROCE of 27.48% are both above the same-industry benchmark median.
About Gujarat Themis Biosyn
Gujarat Themis Biosyn Ltd. is part of the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. Based on the supplied company context, it is a listed Indian pharmaceutical business tracked on NSE and BSE through Gujarat Themis Biosyn Share Price updates. Its market position can be understood through financial and valuation data rather than broad claims about scale or performance.
The company’s current financial snapshot includes market capitalisation, profitability ratios and per-share earnings data that help explain how the stock is being read by the market. For readers following Gujarat Themis Biosyn Stock News or Gujarat Themis Biosyn Latest News, the business context matters because today’s move is easier to assess when set against its industry, earnings base and peer group. Univest presents Gujarat Themis Biosyn Company News in a simple format so users can connect the day’s price rise with the underlying financial profile.
Track Gujarat Themis Biosyn Share Price on Univest
Use Gujarat Themis Biosyn Ltd. (GUJTHEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Investors can track Gujarat Themis Biosyn Share Price on Univest for live updates, Gujarat Themis Biosyn Stock Analysis, Gujarat Themis Biosyn Fundamental Analysis, shareholding pattern insights, market capitalisation, and 52-week levels. Univest also helps users follow Gujarat Themis Biosyn Share Price Today alongside company news, sector context and market updates in one place.
For those reviewing Gujarat Themis Biosyn Share Price Live or Gujarat Themis Biosyn Share Price Update, Univest provides a structured way to monitor the stock without speculation. The idea is to keep the data trail clear, so Gujarat Themis Biosyn Stock Gaining Today is seen in the right numerical context.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Gujarat Themis Biosyn Share Price rising today?
Ans. The data confirms a 5.33% rise to Rs 432.65, but it does not establish a company-specific catalyst. The session also showed a high of Rs 434.30 and turnover of Rs 1.17 crore.
What is Gujarat Themis Biosyn Share Price today?
Ans. Gujarat Themis Biosyn Share Price today is Rs 432.65. It moved up Rs 21.90 from the previous close of Rs 410.75 and stayed within a day’s range of Rs 409.80 to Rs 434.30.
What is Gujarat Themis Biosyn market cap?
Ans. The company’s market capitalisation is Rs 5,345.98 crore. That places Gujarat Themis Biosyn above the same-industry median market cap of Rs 670.73 crore, but below the benchmark average. The company operates in the Healthcare sector.
How does Gujarat Themis Biosyn compare on valuation?
Ans. Gujarat Themis Biosyn Share Price sits alongside a P/E of 109.8 and P/B of 5.1. Both are above the same-industry median and average, which makes valuation an important part of the stock discussion.
What do Gujarat Themis Biosyn profitability ratios show?
Ans. ROE is 21.69% and ROCE is 27.48%, both above the benchmark medians for the same industry. Those figures help explain why Gujarat Themis Biosyn remains visible in stock analysis. ROE stands at 21.69%.
What are the EPS and book value for Gujarat Themis Biosyn?
Ans. EPS is Rs 3.74 and book value is Rs 80.59 per share. EPS shows earnings per share, while book value shows accounting net worth behind each share at the current Gujarat Themis Biosyn Share Price.
How does Gujarat Themis Biosyn compare with peers?
Ans. In the supplied peer set, Gujarat Themis Biosyn has a much smaller market cap than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences and Cipla. Its P/E is also higher than most of those peers.
